Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance

Human Pathology

Volumn 41, Issue 12, 2010, Pages 1702-1710

  Škrtić, Anita ^a   Korać, Petra ^a   Krišto, Delfa Radić ^b   Ajduković Stojisavljević, Radmila ^c   Ivanković, Davor ^a   Dominis, Mara ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b University of Zagreb   (Croatia)

^c University of Zagreb School of Medicine   (Croatia)

Author keywords

IGH translocations; Immunohistochemistry; JAGGED1; Multiple myeloma; NOTCH1

Indexed keywords

JAGGED1; NOTCH1 RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER GROWTH; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL STRUCTURE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PROTEIN EXPRESSION; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; CROATIA; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA; PLASMA CELLS; RECEPTOR, NOTCH1; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 78449281399     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.05.002     Document Type: Article

References (30)

1. Grogan T.M., Van Camp B., Kyle R.A., Muller-Hermelink H.K., and Harris N.L. Plasma cell neoplasms E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman, World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues 2001 IARC Press Lyon (FR)
2. Durie B.G. Cellular and molecular genetic features of myeloma and related disorders Hematol Oncol Clin North Am 6 1992 463 477
3. Salmon S.E., and Seligmann M. Plasma cell neoplasms V.T. De Vita, S. Hellman, S. Rosenberg, Cancer, principles and practice of Oncology 1998 J.B. Lippincott Philadelphia 1854
4. International Myeloma Working Group Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group Br J Haematol 121 2003 749 757
5. Bartl R., Frisch B., and Burkhardt R. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging Br J Haematol 51 1982 361 375
6. Greipp P.R., Leong T., and Bennett J.M. Plasmablastic morphology-an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group Blood 91 1998 2501 2507
7. Bartl R., Frisch B., Fateh-Moghadam A., Kettner G., Jaeger K., and Sommerfeld W. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases Am J Clin Pathol 87 1987 342 355
8. Brunning R.D., and McKenna R.W. Plasma cell dyscrasias and related disorders Atlas of Tumor Pathology 1994 Armed Forces Institute of Pathology Washington, D.C. 323 369
9. Chesi M., Bergsagel P.L., Brents L.A., Smith C.M., Gerhard D.S., and Kuehl W.M. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines Blood 88 1996 674 681
10. González D., van der Burg M., and García-Sanz R. Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma Blood 110 2007 3112 3121
11. Bergsagel P.L., and Kuehl W.M. Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma Immunol Rev 194 2003 96 104
12. Bergsagel P.L., Kuehl W.M., Zhan F., Sawyer J., Barlogie B., and Shaughnessy J. Jr Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma Blood 106 2005 296 303
13. Avet-Loiseau H., Facon T., and Grosbois B. Intergroupe Francophone du Myélome. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation Blood 99 2002 2185 2191
14. Fonseca R., Bailey R.J., and Ahmann G.J. Genomic abnormalities in monoclonal gammopathy of undetermined significance Blood 100 2002 1417 1424
15. Leong K.G., and Karsan A. Recent insights into the role of Notch signaling in tumorigenesis Blood 107 2006 2223 2233
16. Milner L.A., and Bigas A. Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation Blood 93 1999 2431 2448
17. Artavanis-Tsakonas S., Rand M.D., and Lake R.J. Notch signaling: cell fate control and signal integration in development Science 284 1999 770 776
18. Ellisen L.W., Bird J., and West D.C. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms Cell 66 1991 649 661
19. Houde C., Li Y., and Song L. Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines Blood 104 2004 3697 3704
20. Jundt F., Pröbsting K.S., and Anagnostopoulos I. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells Blood 103 2004 3511 3515
21. Nefedova Y., Cheng P., Alsina M., Dalton W.S., and Gabrilovich D.I. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines Blood 103 2004 3503 3510
22. Morimura T., Goitsuka R., Zhang Y., Saito I., Reth M., and Kitamura D. Cell cycle arrest and apoptosis induced by Notch1 in B cells J Biol Chem 275 2000 36523 36531
23. Romer S., Saunders U., Jäck H.M., and Jehn B.M. Notch1 enhances B-cell receptor-induced apoptosis in mature activated B cells without affecting cell cycle progression and surface IgM expression Cell Death Differ 10 2003 833 844
24. Zweidler-McKay P.A., He Y., and Xu L. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies Blood 106 2005 3898 3906
25. Durie B.G., and Salmon S.E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival Cancer 36 1975 842 854
26. Smith A., Wisloff F., Samson D., and UK Myeloma Forum Nordic Myeloma Study Group British Committee for Standards in Haematology Guidelines on the diagnosis and management of multiple myeloma 2005 Br J Haematol. 132 2006 410 451
27. UK Myeloma Forum, and British Committee for Standards in Haematology Diagnosis and management of multiple myeloma Br J Haematol. 115 2001 522 540
28. Olteanu H., Wang H.Y., Chen W., McKenna R.W., and Karandikar N.J. Immunophenotypic studies of monoclonal gammopathy of undetermined significance BMC Clin Pathol 8 2008 13
29. Cook J.R., His E.D., Worley S., Tubbs R.R., and Hussein M. Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival Am J Clin Pathol 125 2006 615 624
30. Ventura R.A., Martin-Subero J.I., and Jones M. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue J Mol Diagn 8 2006 141 151